Study of an oral drug in healthy volunteers
This trial tests an experimental oral drug (called ABBV-1162) in healthy adults to see how the body handles it and to check for any side effects. It is one of the first steps in testing a new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy
- Your blood pressure is less than 140 over 90
- Your resting heart rate is between 55 and 100 beats per minute
- You do not have dizziness when standing up (no sudden drop in blood pressure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests an investigational drug in healthy male volunteers to see how the body absorbs and processes it. Participation may help provide important safety info for future patients, and you will be closely monitored by medical staff.
This trial studies a new drug called ABBV-859 in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.